EtNBS and EtNBS-COOH PDT efficacy in ovarian cancer cells

The effective treatment of metastatic cancer continues to be a challenge due to the highly invasive nature of metastatic lesions and their propensity to develop therapeutic resistance. Optimal therapeutic regimens for peritoneal metastases should have both rapid uptake and penetrate throughout cancerous lesions. Using in vitro models of ovarian cancer, we have found that the cores of tumor nodules are both hypoxic and acidic, rendering most chemotherapeutic agents ineffective, and considerably reducing the therapeutic efficacy of the majority of photodynamic therapy (PDT) and radiation therapy regimens. PDT using EtNBS, a cationic photosensitizer, is a promising approach for treating these hypoxic and acidic nodule cores as it rapidly accumulates into the hypoxic cores of tumor nodules, and is effective even in completely anoxic environments. To improve the uptake rate of EtNBS into cells, we utilized a carboxylic acid terminated derivative of EtNBS that is zwitterionic at biological pH levels. In this study, we investigated the effect of this structural change on PDT efficacy in ovarian cancer cells.

[1]  Aoife M Shannon,et al.  Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. , 2003, Cancer treatment reviews.

[2]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[3]  Tayyaba Hasan,et al.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. , 2010, Chemical reviews.

[4]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[5]  B. Teicher Hypoxia and drug resistance , 1994, Cancer and Metastasis Reviews.

[6]  A. Cincotta,et al.  Novel photodynamic effects of a benzophenothiazine on two different murine sarcomas. , 1994, Cancer research.

[7]  L. Cincotta,et al.  Photodynamic therapy of naturally occurring tumors in animals using a novel benzophenothiazine photosensitizer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[8]  Louis B Harrison,et al.  Impact of tumor hypoxia and anemia on radiation therapy outcomes. , 2002, The oncologist.

[9]  A. Shvarts,et al.  Hypoxia‐Induced Acidification Causes Mitoxantrone Resistance Not Mediated by Drug Transporters in Human Breast Cancer Cells , 2005, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[10]  Ulysses W. Sallum,et al.  Antimicrobial Photodynamic Efficacy of Side‐chain Functionalized Benzo[a]phenothiazinium Dyes , 2009, Photochemistry and photobiology.

[11]  Tayyaba Hasan,et al.  In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging. , 2009, Optics express.

[12]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.